Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
06/30/2025
06/30/2024
06/30/2023
06/30/2022
06/30/2021
Ingresos
12
12
12
9
4
2
Crecimiento de los Ingresos (YoY)
0%
0%
33%
125%
100%
100%
Costo de los ingresos
--
--
--
--
--
--
Utilidad bruta
--
--
--
--
--
--
Venta, General y Administración
12
12
10
8
6
5
Investigación y Desarrollo
4
4
3
2
1
0
Gastos de Operación
13
13
12
10
5
6
Otras Ingresos (Gastos) No Operativos
0
0
0
0
--
--
Ingreso antes de impuestos
-42
-42
-22
-17
-9
-6
Gasto por Impuesto a la Renta
0
0
0
0
0
0
Ingreso Neto
-42
-42
-22
-17
-9
-6
Crecimiento de la Utilidad Neta
91%
91%
28.99%
89%
50%
-14%
Acciones en Circulación (Diluidas)
237.36
237.49
236.1
214.68
196.04
172.76
Cambio de Acciones (YoY)
1%
1%
10%
10%
13%
1%
EPS (Diluido)
-0.17
-0.17
-0.09
-0.08
-0.04
-0.04
Crecimiento de EPS
86%
86%
19%
67%
20%
-12%
Flujo de efectivo libre
2
2
5
-2
0
-4
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
--
--
--
--
--
--
Margen de operación
-8.33%
-8.33%
0%
0%
-25%
-200%
Margen de beneficio
-350%
-350%
-183.33%
-188.88%
-225%
-300%
Margen de flujo de caja libre
16.66%
16.66%
41.66%
-22.22%
0%
-200%
EBITDA
-1
-1
0
0
-1
-4
Margen de EBITDA
-8.33%
-8.33%
0%
0%
-25%
-200%
D&A para EBITDA
0
0
0
0
0
0
EBIT
-1
-1
0
0
-1
-4
Margen de EBIT
-8.33%
-8.33%
0%
0%
-25%
-200%
Tasa de Impuesto Efectiva
0%
0%
0%
0%
0%
0%
Estadísticas clave
Cierre Anterior
$4.8
Precio de apertura
$4.55
Rango del día
$4.55 - $4.65
Rango de 52 semanas
$1.58 - $7.25
Volumen
1.5K
Volumen promedio
17.8K
EPS (TTM)
-0.12
Rendimiento de dividendos
--
Cap. de mercado
$1.2B
¿Qué es Silex Systems Ltd.?
Silex Systems Ltd. engages in the development and commercialization of laser uranium enrichment technology. The company is headquartered in Sydney, New South Wales. The firm is focused on the commercialization of its Separation of Isotopes by Laser EXcitation (SILEX) laser enrichment technology for application to uranium production and enrichment (nuclear power), silicon enrichment (silicon quantum computing) and medical isotope enrichment (new cancer therapies). Its segments include Silex Systems, Translucent and Silex USA. Silex Systems is based in New South Wales and Translucent and Silex USA are based in North Carolina. The SILEX technology has been under development for uranium enrichment jointly with exclusive licensee Global Laser Enrichment LLC. The company is also focused on the development of additional commercial applications of the SILEX technology, including the production of Zero-Spin Silicon for the emerging technology of silicon-based quantum computing. The company has an interest in a semiconductor technology known as cREO through its ownership of subsidiary Translucent Inc.